Covid-19: Regulators warn that rare Guillain-Barré cases may link to J&J and AstraZeneca vaccines
Owen Dyer
Abstract
nervous system, the US Food and Drug Administration has warned.
Topics & Concepts
Guillain-Barre syndromeMedicineVaccinationCoronavirus disease 2019 (COVID-19)Food and drug administrationPediatricsVirologyImmunologyMedical emergencyInternal medicineDiseaseInfectious disease (medical specialty)Long-Term Effects of COVID-19Peripheral Neuropathies and DisordersRetinal and Optic Conditions